Merit Medical Systems Cash Flow from Operating Activities 2012-2026 | MMSI

Merit Medical Systems cash flow from operating activities from 2012 to 2026. Cash flow from operating activities can be defined as a company's cash flows from operations.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Merit Medical Systems Annual Cash Flow Ops
(Millions of US $)
2025 $297
2024 $221
2023 $145
2022 $114
2021 $147
2020 $165
2019 $78
2018 $87
2017 $63
2016 $54
2015 $69
2014 $53
2013 $51
2012 $47
2011 $34
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.072B $1.516B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00